You are here

  • Home
  • Archive
  • Volume 30, Issue Suppl 1
  • 6ER-024 Comparison of reductions in monthly migraine days between new small molecule cgrp receptor antagonists (gepants) and monoclonal antibodies targeting cgrp/cgrp receptor

Article info

Article menu

Download PDFPDF

Section 6: Education and research
6ER-024 Comparison of reductions in monthly migraine days between new small molecule cgrp receptor antagonists (gepants) and monoclonal antibodies targeting cgrp/cgrp receptor
Free

Authors

Citation

Romero-González M, Cordero Ramos J, Valera Rubio M, et al
6ER-024 Comparison of reductions in monthly migraine days between new small molecule cgrp receptor antagonists (gepants) and monoclonal antibodies targeting cgrp/cgrp receptor
European Journal of Hospital Pharmacy 2023;30:A166.

Publication history

  • First published March 23, 2023.
Online issue publication 
May 02, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© European Association of Hospital Pharmacists 2023. No commercial re-use. See rights and permissions. Published by BMJ.